TY  - JOUR 
AU  - Rivera-Caravaca, J.M.
AU  - Anguita Sanchez, M.
AU  - Sanmartín Fernández, M.
AU  - Rafols, C.
AU  - Barón-Esquivias, G.
AU  - Arribas Ynsaurriaga, F.
AU  - Freixa-Pamias, R.
AU  - Lekuona Goya, I.
AU  - Vázquez Rodríguez, José Manuel
AU  - Pérez-Cabeza, A.I.
AU  - Cosín-Sales, J.
AU  - Ureña Montilla, I.
AU  - Álvarez-Vieitez Blanco, A.
AU  - Marín, F.
PY  - 2023
SN  - 1879-1913
UR  - http://hdl.handle.net/20.500.11940/21028
AB  - Renal impairment confers worse prognosis in patients with atrial fibrillation (AF) but there is scarce evidence about the influence of direct-acting oral anticoagulants in routine clinical practice. Herein, we compared clinical outcomes between...
LA  - eng
KW  - Humans
KW  - Male
KW  - Rivaroxaban
KW  - Atrial Fibrillation
KW  - Stroke
KW  - Ischemic Attack, Transient
KW  - Hemorrhage
KW  - Renal Insufficiency
KW  - Myocardial Infarction
KW  - Heart Failure
KW  - Anticoagulants
KW  - Risk Factors
TI  - Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment
DO  - 10.1016/j.amjcard.2023.06.105
T2  - American Journal of Cardiology
M2  - 122
KW  - AS A Coruña
KW  - CHUAC
VL  - 203
ER  -